Understanding protection from SARS-CoV-2 by studying reinfection.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.Emerging microbes & infections · 2022
   Pooled it
2. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.Archives of virology · 2022
   Review
3. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
   Article
4. SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021.BMC infectious diseases · 2022
   Article
5. Transmission dynamics of COVID-19 pandemic with combined effects of relapse, reinfection and environmental contribution: A modeling analysis.Results in physics · 2022
   Article
6. Comparison of BNT162b2-, mRNA-1273- and Ad26.COV2.S-Elicited IgG and Neutralizing Titers against SARS-CoV-2 and Its Variants.Vaccines · 2022
   Article
7. Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease-Empirical Evidence from a Large Population-Based Italian Platform.Vaccines · 2022
   Article
8. The Effect of Varying Interval Definitions on the Prevalence of SARS-CoV-2 Reinfections: A Retrospective Cross-Sectional Cohort Study.Diagnostics (Basel, Switzerland) · 2022
   Article
9. Eight Good Reasons for Careful Monitoring and Evaluation of the Vaccine Campaign against COVID-19: Lessons Learned through the Lombardy Experience for Dealing with Next Challenges.International journal of environmental research and public health · 2022
   Review
10. SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies.The Journal of clinical investigation · 2022
    Article
11. Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States.Frontiers in public health · 2022
    Article
12. No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2021
    Observational
13. COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms.Biochemical engineering journal · 2021
    Review
14. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?The Lancet. Respiratory medicine · 2021
    Review
15. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.The lancet. Healthy longevity · 2021
    Observational
16. Anti-spike antibody response to natural SARS-CoV-2 infection in the general population.Nature communications · 2021
    Article
17. Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination.Vaccines · 2021
    Review
18. Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.The Journal of infection · 2021
    Article
19. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.The Lancet. Respiratory medicine · 2021
    Article
20. Re-infection of SARS-CoV-2: A case in a young dental healthcare worker.Journal of infection and public health · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as